T. Abekawa

发表

Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex

Koki Ito, Tsukasa Koyama, S. Nakagawa, 2008, Schizophrenia Research.

Abnormalities in extracellular glycine and glutamate levels in the striatum of sandy mice

R. Hashimoto, Takeshi Inoue, T. Koyama, 2013, Acta Neuropsychiatrica.

Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats

Takeshi Inoue, T. Koyama, Koki Ito, 2011, Neuroscience Letters.

Lamotrigine blocks the initiation and expression of repeated high-dose methamphetamine-induced prepulse inhibition deficit in rats

Takeshi Inoue, T. Koyama, Koki Ito, 2010, Neuroscience Letters.

Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.

Takeshi Inoue, S. Nakagawa, T. Koyama, 2011, Journal of affective disorders.

Environment modifies the expression of behavioral sensitization produced by methamphetamine: behavioral and neurochemical studies

T. Ohmori, T. Koyama, T. Abekawa, 1995, Behavioural pharmacology.

Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine

T. Ohmori, T. Koyama, T. Abekawa, 1994, Pharmacology Biochemistry and Behavior.

Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine

T. Koyama, T. Inoue, T. Abekawa, 2002, Psychopharmacology.

Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment

T. Ohmori, T. Koyama, T. Abekawa, 1995, Psychopharmacology.

The Role of Benzodiazepine Receptors in the Acquisition and Expression of Behavioral Sensitization to Methamphetamine

T. Ohmori, T. Koyama, T. Abekawa, 2000, Pharmacology Biochemistry and Behavior.

Clonazepam Prevents the Development of Sensitization to Methamphetamine

K Ito, T. Ohmori, T. Koyama, 1997, Pharmacology Biochemistry and Behavior.

Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine

T. Koyama, T. Abekawa, K. Ito, 2006, Psychopharmacology.

Scopolamine prevents the development of sensitization to methamphetamine.

T. Ohmori, T. Koyama, T. Abekawa, 1995, Life sciences.

Methamphetamine-Induced Behavioral Abnormalities and Neuronal Apoptosis

T. Abekawa, 2016 .

Context determines the type of sensitized behaviour: a brief review and a hypothesis on the role of environment in behavioural sensitization

T. Ohmori, T. Koyama, T. Abekawa, 2000, Behavioural pharmacology.

Developmental GABAergic deficit enhances methamphetamine-induced apoptosis

T. Koyama, Koki Ito, Yasuya Nakato, 2011, Psychopharmacology.

Psychotic relapse and maintenance therapy in paranoid schizophrenia: a 15 year follow up

T. Ohmori, T. Koyama, T. Abekawa, 1999, European Archives of Psychiatry and Clinical Neuroscience.

Effect of the protein kinase C inhibitor, staurosporine, on the high dose of methamphetamine-induced behavioral sensitization to dizocilpine (MK-801)

T. Koyama, T. Inoue, T. Abekawa, 2005, Psychopharmacology.

Differences between bipolar and unipolar depression on Rorschach testing

Takeshi Inoue, Hiromi Kimura, S. Nakagawa, 2013, Neuropsychiatric disease and treatment.

Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats

S. Nakagawa, T. Koyama, Koki Ito, 2007, Psychopharmacology.

Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine

T. Ohmori, T. Koyama, T. Abekawa, 1994, Brain Research.

[Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].

T. Abekawa, 1997, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

Effect of no synthesis inhibition on striatal dopamine release and stereotyped behavior induced by a single administration of methamphetamine

T. Ohmori, T. Koyama, T. Abekawa, 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine

T. Ohmori, T. Koyama, T. Abekawa, 1995, Brain Research.

Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatum

T. Ohmori, T. Koyama, T. Abekawa, 2001, Journal of Neural Transmission.

Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala.

Takeshi Izumi, Tsukasa Koyama, Takeshi Inoue, 2004, European journal of pharmacology.

Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex

T. Koyama, T. Abekawa, K. Ito, 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens

T. Ohmori, T. Koyama, T. Abekawa, 1994, Brain Research.

Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and α1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats

T. Koyama, Koki Ito, T. Abekawa, 2003, Psychopharmacology.

Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic

T. Koyama, Koki Ito, T. Abekawa, 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala.

Xiaobai Li, Takeshi Inoue, S. Nakagawa, 2006, European journal of pharmacology.

Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine

T. Koyama, Koki Ito, T. Abekawa, 2006, Psychopharmacology.

D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex

Tsukasa Koyama, Tetsuro Ohmori, T. Ohmori, 2000, Brain Research.

Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents

S. Nakagawa, T. Koyama, Koki Ito, 2011, Schizophrenia Research.

Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine

T. Ohmori, T. Koyama, T. Abekawa, 1997, Brain Research.

Differences between bipolar and unipolar depression on Rorschach testing

Takeshi Inoue, Hiromi Kimura, S. Nakagawa, 2013 .

Lamotrigine blocks apoptosis induced by repeated administration of high-dose methamphetamine in the medial prefrontal cortex of rats

Takeshi Inoue, T. Koyama, Koki Ito, 2011, Neuroscience Letters.

Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine

Takeshi Inoue, T. Koyama, T. Abekawa, 2002, Brain Research.

Differences between bipolar and unipolar depression on Rorschach testing

Takeshi Inoue, Hiromi Kimura, S. Nakagawa, 2013, Neuropsychiatric disease and treatment.

Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain

T. Ohmori, T. Abekawa, Tomiyasu Koyama, 2005, Journal of Neural Transmission.